Clinical Trial Update: Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients

View source ↗

Summary

An observational study evaluating a triple combination therapy including Zemidapa tablets and Metformin in adults with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Zemidapa Tab.
• metformin (metformin)

Snippet

Sponsor: LG Chem | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED